Locations in over 50 countries with 29 manufacturing facilities and 7 R&D centres
Europe
We manufacture injectable medicines in Europe, supplying products to the US, the MENA, and Europe. We have high-quality manufacturing facilities in Germany, Italy and Portugal.
Middle East and North Africa (MENA)
The region’s principal player, we create branded generic medicines and are a leading licensing partner. We’re the fifth largest pharmaceutical manufacturer in the territory.
US
We are a top three player by volume in generic injectable medicines and have a strong presence in the non-injectable generics market.
Rest of the World
We are strengthening and expanding our direct presence in emerging markets and Asia Pacific and establishing strategic partnerships in the rest of the world.
Latest news
Hikma launches Abiraterone Acetate Tablets
14 February 2019
Hikma launches Mitomycin for Injection, USP
29 January 2019